CYTOTOXIC DRUGS

Clinical trials for CYTOTOXIC DRUGS explained in plain language.

Never miss a new study

Get alerted when new CYTOTOXIC DRUGS trials appear

Sign up with your email to follow new studies for CYTOTOXIC DRUGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope to keep cancer treatment on track

Disease control Not yet recruiting

This study is testing if a drug called romiplostim N01 can help breast cancer patients recover their platelet counts after chemotherapy. Low platelets (thrombocytopenia) are a common side effect that can delay cancer treatment. The study will see if weekly injections of the drug …

Matched conditions: CYTOTOXIC DRUGS

Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

CYTOTOXIC DRUGS

Get alerted when new CYTOTOXIC DRUGS trials appear

New hope to keep cancer treatment on track